Two Sigma Advisers »

Amylyx Pharmaceuticals shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.2M 1.2M 1.90
2024-03-31 $2.3M 799k 2.84

More positions owned by Two Sigma Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Costco Wholesale Corporation (COST)
Uber Technologies (UBER)
Mastercard Incorporated Cl A (MA)
Pfizer (PFE)
Crowdstrike Hldgs Cl A (CRWD)
Micron Technology (MU)
Abbott Laboratories (ABT)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Two Sigma Advisers

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals